Stocksigma LogoStocksigma Logo

Aurobindo Pharma Board to Consider Q2 Results and Interim Dividend

Aurobindo Pharma's Board of Directors is scheduled to meet on 4th Nov'26 to consider and approve the standalone and consolidated unaudited financial

Aurobindo Pharma Board to Consider Q2 Results and Interim Dividend

Aurobindo Pharma Ltd 路 Intimation 路 04 Nov 2026, 5:30 am

Aurobindo Pharma Board to Consider Q2 Results and Interim Dividend Aurobindo Pharma's Board of Directors is scheduled to meet on 4th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the second quarter and half year ended 30th Sep'26. Additionally, the board will evaluate the declaration of an interim dividend for FY27. In compliance with insider trading regulations, the company's trading window remains closed until 6th Nov'26 and will reopen on 7th Nov'26.

Original exchange filing (PDF)

More announcements from Aurobindo Pharma Ltd

All Aurobindo Pharma Ltd announcements